James Chalmers to Adult
This is a "connection" page, showing publications James Chalmers has written about Adult.
Connection Strength
0.135
-
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J. 2021 04; 57(4).
Score: 0.016
-
Bronchiectasis: a case-based approach to investigation and management. Eur Respir Rev. 2018 Sep 30; 27(149).
Score: 0.013
-
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Respir Res. 2018 04 11; 19(1):63.
Score: 0.013
-
Bronchiectasis Exacerbations Are Heart-Breaking. Ann Am Thorac Soc. 2018 03; 15(3):301-303.
Score: 0.013
-
Bronchiectasis: new therapies and new perspectives. Lancet Respir Med. 2018 09; 6(9):715-726.
Score: 0.012
-
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD. Thorax. 2018 06; 73(6):510-518.
Score: 0.012
-
European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017 09; 50(3).
Score: 0.012
-
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017 Jun 29; 27(1):43.
Score: 0.012
-
COVID-19, individual wellbeing and multi-dimensional poverty in the state of South Australia. PLoS One. 2021; 16(6):e0252898.
Score: 0.004
-
Economic burden of bronchiectasis in Germany. Eur Respir J. 2019 02; 53(2).
Score: 0.003
-
British Thoracic Society Guideline for bronchiectasis in adults. Thorax. 2019 01; 74(Suppl 1):1-69.
Score: 0.003
-
How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis. Int J Mol Sci. 2018 Oct 20; 19(10).
Score: 0.003
-
Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018 07; 52(1).
Score: 0.003
-
Continuous versus intermittent antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018 06 03; 6:CD012733.
Score: 0.003
-
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis. BMC Pulm Med. 2018 May 22; 18(1):83.
Score: 0.003
-
Oral versus inhaled antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018 03 27; 3:CD012579.
Score: 0.003
-
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med. 2018 04; 137:6-13.
Score: 0.003
-
A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study. Chest. 2017 08; 152(2):368-378.
Score: 0.003